Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5926 USD | -0.40% | -30.17% | +11.81% |
Apr. 16 | BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 29 | BioNexus Gene Lab Corp. Provides Information to Shareholders | CI |
Financials (USD)
Sales 2022 | 10.93M | Sales 2023 | 9.77M | Capitalization | 9.36M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | -2M | EV / Sales 2022 | 14.9 x |
Net cash position 2022 | 2.06M | Net cash position 2023 | 5.78M | EV / Sales 2023 | 0.37 x |
P/E ratio 2022 |
-461
x | P/E ratio 2023 |
-3.2
x | Employees | 30 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.63% |
1 day | -0.40% | ||
1 week | -30.17% | ||
Current month | -16.06% | ||
1 month | -17.92% | ||
3 months | +9.34% | ||
6 months | +36.04% | ||
Current year | +11.81% |
Managers | Title | Age | Since |
---|---|---|---|
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chee Keong Yap
BRD | Director/Board Member | 68 | 22-03-06 |
Wei Foong Lim
BRD | Director/Board Member | 48 | Dec. 10 |
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.5926 | -0.40% | 44,884 |
24-04-24 | 0.595 | +2.23% | 56,993 |
24-04-23 | 0.582 | -6.13% | 156,866 |
24-04-22 | 0.62 | +3.37% | 295,592 |
24-04-19 | 0.5998 | -29.32% | 735,884 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+11.81% | 10.47M | |
-17.89% | 8.36B | |
+40.49% | 3.6B | |
-32.64% | 2.73B | |
-7.88% | 2.47B | |
-7.35% | 2.32B | |
-14.40% | 1.77B | |
-18.74% | 1.55B | |
-40.19% | 1.22B | |
+5.57% | 1.09B |
- Stock Market
- Equities
- BGLC Stock